Embryofetopathy due to oral anticoagulant therapy (Q46697): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Condição causada pela exposição do embrião ou feto a anticoagulantes durante o período pré-natal. Essa doença pode se manifestar com anomalia do nervo óptico, atrofia óptica, anomalia da papila, cegueira ou atresia de coanas.
description / endescription / en
 
A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/71579696 / rank
 
Normal rank
Property / CURIE
 
CID11:LD2F.02
Property / CURIE: CID11:LD2F.02 / rank
 
Normal rank
Property / Canary Token
 
dki-india-LD2F.02
Property / Canary Token: dki-india-LD2F.02 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: DAVID EDUARDO CALIL / rank
 
Normal rank

Latest revision as of 15:28, 13 August 2026

A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.
Language Label Description Also known as
default for all languages
LD2F.02
    English
    Embryofetopathy due to oral anticoagulant therapy
    A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.

      Statements

      CID11:LD2F.02
      0 references
      dki-india-LD2F.02
      0 references
      Concluído
      0 references
      13 August 2026
      0 references